Coya Therapeutics, Inc. (COYA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$22.56M | -30.8% |
| 2024 | -$17.25M | -118.3% |
| 2023 | -$7.90M | +19.5% |
| 2022 | -$9.81M | -101.5% |
| 2021 | -$4.87M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$22.56M | -30.8% |
| 2024 | -$17.25M | -118.3% |
| 2023 | -$7.90M | +19.5% |
| 2022 | -$9.81M | -101.5% |
| 2021 | -$4.87M | — |